Long-Term effects of COVID-19 on lung and cardiovascular health: a state-of-the-art review
Section: Communication for health
DOI:
https://doi.org/10.5281/zenodo.10296563Keywords:
COVID-19, post-COVID syndrome, pulmonary system, cardiovascular systemAbstract
COVID 19 became a pandemic that affected millions of people around the world; Its consequences and impact on humanity were immeasurable, and health policies and the efforts of institutions and states focused on preventing the spread of the virus and on health systems to increase the capacity to respond to the pandemic. This paper focuses on the problematic consequences for patients recovering from COVID-19, in order to contribute to the scientific debate on this topic. This is very important in the current context because, in addition to causing respiratory damage and fibrosis, COVID-19 also tends to affect the cardiovascular system, causing cardiomyopathy and myocarditis and worsening pre-existing cardiovascular diseases to some extent. The purpose of this article is to explain the pulmonary and cardiovascular effects of Covid-19 described in the literature so far and to suggest some interventions for patients to recover.
Downloads
References
Bansal, M. (2020). Cardiovascular disease and COVID-19. Diabetes & metabolic syndrome 14(3), 247–250. https://doi.org/10.1016/j.dsx.2020.03.013.
Behar, R. D. (2008). Metodologia de la investigación. (A. Rubeira, Ed.) Editorial Shalom. Recuperado el 22 de Mayo de 2020.
Campos, O. P. (2020). La importancia de la investigación formativa como estrategia de aprendizaje. EDUCARE ET COMUNICARE: Revista científica de la Facultad de Humanidades, 8(1), 88-94. https://doi.org/10.35383/educare.v8i1.397.
Cequier, F. Á., & Gonzalez, J. J. (2020). Conclusiones. COVID-19, del juicio clínico a la evidencia científica. Revista Española de Cardiología , 40-42.
Chen, D., Li, X., Song, Q., & al., e. (2020.). Hypokalemia and Clinical Implications in Patients with Coronavirus Disease 2019 (COVID-19). medRxiv, https://doi.org/10.1101/2020.02.27.20028530.
Giudicessi, J. R., Noseworthy, P. A., Friedman, P. A., & Ackerman, M. J. (2020). Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). Mayo Clinic proceedings, 95(6), 1213–1221. https://doi.org/10.1016/j.mayocp.2020.03.024.
Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., . . . Ex, …. C. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. The New England journal of medicine, 382(18), 1708–1720. https://doi.org/10.1056/NEJMoa2002032.
Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Liu, L., Shan, H., Lei, C. L., Hui, D. S. C., Du, B., Li, L. J., Zeng, G., Yuen, K. Y., Chen, R. C., Tang, C. L., Wang, T., Chen, P. Y., Xiang, J., Li, S. Y. China Medical Treatment Exper. (2020). Clinical characteristics of coronavirus disease 2019 in China. The New England journal of medicine. 382(18), 1708–1720. https://doi.org/10.1056/NEJMoa2002032.
Gutiérrez, B., Mosqueda, M., Joaquín, V., Morales, F., Cruz, S., Chávez, A., & al, e. (2021). Efectos a largo plazo de la COVID-19: una revisión de la literatura. Acta Med Grupo Angeles, 19 (3): 421-428. https://dx.doi.org/10.35366/101741.
Han, Y., Zeng, H., Jiang, H., Yang, Y., Yuan, Z., Cheng, X., . . . Ma, C. ( 2020). CSC expert consensus on principles of clinical management of patients with severe emergent cardiovascular diseases during the COVID-19 epidemic. Circulation, 141(20), e810– e816. https://doi.org/10.1161/CIRCULATIONAHA.120.047011.
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., . . . Pöhlmann, S. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 181(2), 271–280.e8. https://doi.org/10.1016/j.cell.2020.02.052.
Hopkins, J. M. (29 de julio de 2022). Johns Hopkins Medicine. Obtenido de Johns Hopkins Medicine. ¿Qué es el coronavirus?: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus
Huang C, H. L. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet., 397 (10270): 220-232.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., . . . al., e. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England), 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5.
Jimenez, B. (2023). ESTUDIO MULTIDIMENSIONAL DE LA CONDICIÓN POST COVID-19. Granada: Universidad de Granada.
Liu, T., Wu, D., Yan, W., Wang, X., Zhang, X., Ma, K., . . . Ning, Q. (2022). Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, China. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 74(11), 1953–1965. https://doi.org/10.1093/cid/ciab703.
Llamosas, L. S. (2020). SECUELAS A LARGO PLAZO DE COVID-19. PERSPECTIVA.
Revista Española de Salud Pública.
López, J., Cárdenas, P., Germán, G., & Herrera, Á. (2020). Coronavirus – COVID 19: Más allá de la enfermedad pulmonar, qué es y qué sabemos del vínculo con el sistema cardiovascular. Revista Colombiana de Cardiología, 27(3), 142-152.
MCKEEVER, A. (2021). Así ataca la COVID-19 a nuestro corazón. NATIONAL GEOGRAPHIC, Recuperado:
https://www.nationalgeographic.es/ciencia/2021/12/asi-ataca-la-covid-19-a-nuestro-corazon.
OMS, O. M. (25 de octubre de 2023). Worl Health Organization. Obtenido de Panel de control del coronavirus (COVID-19) de la OMS: https://covid19.who.int/
OMS, O. M. (9 de agosto de 2023). World Health Organization. Obtenido de World Health Organization: Enfermedad por coronavirus (COVID-19): https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-(covid-19)
Osman, W. A., Ahmed, A. A., Elawad, O. A., & Albashir, A. P. (2020). Un caso de pericarditis aguda y posterior derrame pericárdico en paciente con COVID-19: reporte de un caso. Autorea, 10.22541/au.159969834.49964606.
Ponce, L. L., Muñiz, T. S., Mastarreno, C. M., & Villacreses, H. G. (2020). Secuelas que enfrentan los pacientes que superan el COVID 19. RECIMUNDO. 10.26820/recimundo/4.(3), 153-162.
Shi, Q., & Montgomery, R. R. (2010). Platelets as delivery systems for disease treatments. Advanced drug delivery reviews, 62(12, 1196–1203. https://doi.org/10.1016/j.addr.2010.06.007.
Tasnim, A. C. (23 de Febrero de 2022). CORONAVIRUS. Las personas con covid-19 pueden enfrentar complicaciones cardiovasculares a largo plazo, según un estudio, págs. Recuperado: https://cnnespanol.cnn.com/2022/02/23/covid-largo-complicaciones-cardiovasculares-salud-trax/.
Visconti, N., Cailleaux-Cezar, M., Capone, D., Santos, M., Graça, N., Loivos, L., & al., e. (2022). Long-term respiratory outcomes after COVID-19: a Brazilian cohort study. Rev Panam Salud Publica, 46:e187. https://doi.org/10.26633/RPSP.2022.187.
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., . . . Peng, Z. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323(11), 1061–1069. https://doi.org/10.1001/jama.2020.1585.
Wu Z, M. J. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA, 323(13), 1239–1242. https://doi.org/10.1001/jama.2020.2648.
Yelin, D., Wirtheim, E., Vetter, P., Kalil, A. C., Bruchfeld, J., Runold, M., . . . Leibovici, L. (2020). Long-term consequences of COVID-19: research needs. The Lancet. Infectious diseases, 20(10), 1115–1117. https://doi.org/10.1016/S1473-3099(20)30701-5.
Yu, M., Liu, Y., Xu, D., Zhang, R., Lan, L., & Xu, H. (2020). Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia. Korean journal of radiology, 21(6), 746–755. https://doi.org/10.3348/kjr.2020.0215.
Zheng, Y. Y., Ma, Y. T., Zhang, J. Y., & Xie, X. (2020). COVID-19 and the cardiovascular system. Nature reviews. Cardiology, 17(5), 259–260. https://doi.org/10.1038/s41569-020-0360-5.
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., . . . Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England), 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3.
Zhou, S., Wang, Y., Zhu, T., & Xia, L. (2020). C T features of coronavirus disease 2019 (COVID-19 )pneumoniain 62 patientsin Wuhan,China. American Journal of Roentgenology, vol. 214, no. 6, pp.1287–1294.
Zhu, N.; Zhang, D.; Wang, W.; Li, X; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R., Niu, P.; Zhan, F.; Ma, X.; Wang, D.; Xu, W.; Wu, G.; Gao, G. F.; Tan, W.; China Novel Coronavirus Investigating and Research Team. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England journal of medicine, 382(8), 727–733. https://doi.org/10.1056/NEJMoa2001017.
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
The journal is licensed under the Attribution License (CC BY), allowing the possibility of copying, distributing, displaying, and producing derivative works, as long as the author is acknowledged and cited.
